Kerri L LaRovere, Matthew Luchette, Alireza Akhondi-Asl, Bradley J DeSouza, Robert C Tasker, Nilesh M Mehta, Alon Geva
{"title":"心率变化作为急性灾难性脑损伤危重儿童脑死亡的潜在数字生物标志物","authors":"Kerri L LaRovere, Matthew Luchette, Alireza Akhondi-Asl, Bradley J DeSouza, Robert C Tasker, Nilesh M Mehta, Alon Geva","doi":"10.1097/CCE.0000000000000908","DOIUrl":null,"url":null,"abstract":"<p><p>Bedside measurement of heart rate (HR) change (HRC) may provide an objective physiologic marker for when brain death (BD) may have occurred, and BD testing is indicated in children.</p><p><strong>Objectives: </strong>To determine whether HRC, calculated using numeric HR measurements sampled every 5 seconds, can identify patients with BD among patients with catastrophic brain injury (CBI).</p><p><strong>Design setting and participants: </strong>Single-center, retrospective study (2008-2020) of critically ill children with acute CBI. Patients with CBI had a neurocritical care consultation, were admitted to an ICU, had acute neurologic injury on presentation or during hospitalization based on clinical and/or imaging findings, and died or survived with Glasgow Coma Scale (GCS) less than 13 at hospital discharge. Patients meeting BD criteria (BD group) were compared with those with cardiopulmonary death (CD group) or those who survived to discharge.</p><p><strong>Main outcomes and measures: </strong>HRC was calculated as the interquartile range of HR divided by median HR using 5-minute windows with 50% overlap for up to 5 days before death or end of recording. HRC was compared among the BD, CD, and survivor groups.</p><p><strong>Results: </strong>Of 96 patients with CBI (69% male, median age 4 years), 28 died (8 BD, 20 CD) and 20 survived (median GCS 9 at discharge). Within 24 hours before death, HRC was lower in BD compared with CD patients or survivors (0.01 vs 0.03 vs 0.04, <i>p</i> = 0.001). In BD patients, HRC decreased at least 1 day before death. HRC discriminated BD from CD patients and survivors with 90% sensitivity, 70% specificity, 44% positive predictive value, 96% negative predictive value (area under the receiver operating characteristic curve 0.88, 95% CI, 0.80-0.93).</p><p><strong>Conclusions and relevance: </strong>HRC is a novel digital biomarker that, with further validation, may be useful as a classifier for BD in the overall course of patients with CBI.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 5","pages":"e0908"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/5b/cc9-5-e0908.PMC10158912.pdf","citationCount":"0","resultStr":"{\"title\":\"Heart Rate Change as a Potential Digital Biomarker of Brain Death in Critically Ill Children With Acute Catastrophic Brain Injury.\",\"authors\":\"Kerri L LaRovere, Matthew Luchette, Alireza Akhondi-Asl, Bradley J DeSouza, Robert C Tasker, Nilesh M Mehta, Alon Geva\",\"doi\":\"10.1097/CCE.0000000000000908\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bedside measurement of heart rate (HR) change (HRC) may provide an objective physiologic marker for when brain death (BD) may have occurred, and BD testing is indicated in children.</p><p><strong>Objectives: </strong>To determine whether HRC, calculated using numeric HR measurements sampled every 5 seconds, can identify patients with BD among patients with catastrophic brain injury (CBI).</p><p><strong>Design setting and participants: </strong>Single-center, retrospective study (2008-2020) of critically ill children with acute CBI. Patients with CBI had a neurocritical care consultation, were admitted to an ICU, had acute neurologic injury on presentation or during hospitalization based on clinical and/or imaging findings, and died or survived with Glasgow Coma Scale (GCS) less than 13 at hospital discharge. Patients meeting BD criteria (BD group) were compared with those with cardiopulmonary death (CD group) or those who survived to discharge.</p><p><strong>Main outcomes and measures: </strong>HRC was calculated as the interquartile range of HR divided by median HR using 5-minute windows with 50% overlap for up to 5 days before death or end of recording. HRC was compared among the BD, CD, and survivor groups.</p><p><strong>Results: </strong>Of 96 patients with CBI (69% male, median age 4 years), 28 died (8 BD, 20 CD) and 20 survived (median GCS 9 at discharge). Within 24 hours before death, HRC was lower in BD compared with CD patients or survivors (0.01 vs 0.03 vs 0.04, <i>p</i> = 0.001). In BD patients, HRC decreased at least 1 day before death. HRC discriminated BD from CD patients and survivors with 90% sensitivity, 70% specificity, 44% positive predictive value, 96% negative predictive value (area under the receiver operating characteristic curve 0.88, 95% CI, 0.80-0.93).</p><p><strong>Conclusions and relevance: </strong>HRC is a novel digital biomarker that, with further validation, may be useful as a classifier for BD in the overall course of patients with CBI.</p>\",\"PeriodicalId\":10759,\"journal\":{\"name\":\"Critical Care Explorations\",\"volume\":\"5 5\",\"pages\":\"e0908\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/5b/cc9-5-e0908.PMC10158912.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Explorations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CCE.0000000000000908\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000000908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
床边测量心率(HR)变化(HRC)可能为何时可能发生脑死亡(BD)提供客观的生理标记,BD检测适用于儿童。目的:确定HRC是否可以在灾难性脑损伤(CBI)患者中识别出BD患者,HRC通过每5秒采样一次的数值HR测量来计算。设计背景和参与者:单中心回顾性研究(2008-2020)急性CBI危重儿童。CBI患者接受神经危重症会诊,住进ICU,就诊时或住院期间根据临床和/或影像学表现出现急性神经损伤,出院时格拉斯哥昏迷评分(GCS)低于13分死亡或存活。符合BD标准的患者(BD组)与心肺死亡患者(CD组)或存活至出院的患者进行比较。主要结局和测量:HRC计算为HR的四分位数范围除以中位数HR,使用5分钟窗口,在死亡或记录结束前5天内重叠50%。比较BD组、CD组和幸存者组的HRC。结果:96例CBI患者(69%为男性,中位年龄4岁),28例死亡(8例BD, 20例CD), 20例存活(出院时中位GCS为9)。死亡前24小时内,BD患者的HRC较CD患者或幸存者低(0.01 vs 0.03 vs 0.04, p = 0.001)。在BD患者中,HRC在死亡前至少1天下降。HRC区分BD与CD患者和幸存者的敏感性为90%,特异性为70%,阳性预测值为44%,阴性预测值为96%(受试者工作特征曲线下面积0.88,95% CI, 0.80-0.93)。结论和相关性:HRC是一种新的数字生物标志物,经过进一步验证,可能有助于在CBI患者的整个病程中作为BD的分类器。
Heart Rate Change as a Potential Digital Biomarker of Brain Death in Critically Ill Children With Acute Catastrophic Brain Injury.
Bedside measurement of heart rate (HR) change (HRC) may provide an objective physiologic marker for when brain death (BD) may have occurred, and BD testing is indicated in children.
Objectives: To determine whether HRC, calculated using numeric HR measurements sampled every 5 seconds, can identify patients with BD among patients with catastrophic brain injury (CBI).
Design setting and participants: Single-center, retrospective study (2008-2020) of critically ill children with acute CBI. Patients with CBI had a neurocritical care consultation, were admitted to an ICU, had acute neurologic injury on presentation or during hospitalization based on clinical and/or imaging findings, and died or survived with Glasgow Coma Scale (GCS) less than 13 at hospital discharge. Patients meeting BD criteria (BD group) were compared with those with cardiopulmonary death (CD group) or those who survived to discharge.
Main outcomes and measures: HRC was calculated as the interquartile range of HR divided by median HR using 5-minute windows with 50% overlap for up to 5 days before death or end of recording. HRC was compared among the BD, CD, and survivor groups.
Results: Of 96 patients with CBI (69% male, median age 4 years), 28 died (8 BD, 20 CD) and 20 survived (median GCS 9 at discharge). Within 24 hours before death, HRC was lower in BD compared with CD patients or survivors (0.01 vs 0.03 vs 0.04, p = 0.001). In BD patients, HRC decreased at least 1 day before death. HRC discriminated BD from CD patients and survivors with 90% sensitivity, 70% specificity, 44% positive predictive value, 96% negative predictive value (area under the receiver operating characteristic curve 0.88, 95% CI, 0.80-0.93).
Conclusions and relevance: HRC is a novel digital biomarker that, with further validation, may be useful as a classifier for BD in the overall course of patients with CBI.